CG Oncology (CGON) Interest Coverage Ratio (2023 - 2026)
CG Oncology (CGON) posted Interest Coverage Ratio of 0.17 for Q1 2026, up 99.93% on a QoQ basis from 237.56 in Q4 2025, and up 64.13% year-over-year from 0.11 in Q1 2025.
CG Oncology (CGON) Interest Coverage Ratio (2023 - 2026) Analysis & Trends
CG Oncology's Interest Coverage Ratio history runs 4 years deep, the most recent figure standing at 0.17 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 64.13% year-over-year to 0.17 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.56 (up 63.53% YoY) and the FY2025 annual result came in at 0.96, up 9.37% from the prior year.
- Interest Coverage Ratio was 0.17 for Q1 2026 at CG Oncology, up from 237.56 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 0.1 in Q1 2024 and bottomed at 634.15 in Q4 2024.
- A 4-year average of 118.44 and a median of 0.47 in 2025 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2024 — Interest Coverage Ratio soared 99.94% — and 2025, when it tumbled 397.37%.
- CG Oncology's Interest Coverage Ratio stood at 238.02 in 2023, then slumped by 166.43% to 634.15 in 2024, then surged by 62.54% to 237.56 in 2025, then jumped by 99.93% to 0.17 in 2026.
- Business Quant data shows CGON's Interest Coverage Ratio at 0.17 in Q1 2026, 237.56 in Q4 2025, and 0.27 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | CG Oncology | 6.01 Bn | 6.01 Bn | -1.88 Mn | -0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.17 |
| Dec 31, 2025 | -237.56 |
| Sep 30, 2025 | -0.27 |
| Jun 30, 2025 | -0.46 |
| Mar 31, 2025 | -0.48 |
| Dec 31, 2024 | -634.15 |
| Sep 30, 2024 | -0.18 |
| Jun 30, 2024 | -0.17 |
| Mar 31, 2024 | -0.10 |
| Sep 30, 2023 | -238.02 |
| Jun 30, 2023 | -273.91 |
| Mar 31, 2023 | -35.87 |